Substance Abuse Treatment Market

Substance Abuse Treatment Market (Treatment Type - Drug Abuse Treatment (Methadone, Buprenorphine, Naltexone), Nicotine Addiction Treatment (Total NRT Therapy, Varenicline, Bupropion), Alcohol Addiction Treatment (Acamprosate, Disulphirum, Naltrexone, Benzodiazepines); Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Drug Stores, Others (Online Sales)) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

  • Rep Id : TMRGL4067
  • Published On : Mar 2019
  • No. of Pages : 217
  • Category : Healthcare

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights
     1.3. Assumptions and Acronyms Used

2. Research Methodology 

3. Executive Summary

4. Market Overview
     4.1. Introduction
     4.2. Key Industry Evolution/Developments
     4.3. Market Dynamics
           4.3.1. Drivers
                    4.3.1.1. Awareness about Initiatives by Manufacturers and Governments 
                    4.3.1.2. Favorable Reimbursements for Smoking Cessation Therapy and Growth in the Number of Private Insurance Players
                    4.3.1.3. Surge in Disposable Income
                    4.3.1.4. Growing Abuse of Prescription Drugs 
           4.3.2. Restraints
                    4.3.2.1. Low Awareness about Addiction Treatment Products in Developing Countries
                    4.3.2.2. Legal Obligations for Addiction Treatment Products
           4.3.3. Opportunities
                    4.3.3.1. Research and Development
                    4.3.3.2. Introduction of New Products
           4.3.4. Trends 
                    4.3.4.1. Rise in Mergers and Acquisitions in the Industry
                    4.3.4.2. Government Initiatives and Funding
     4.4. Global Substance Abuse Treatment Market Forecast
     4.5. Porter’s Five Forces
     4.6. Pipeline Analysis 
     4.7. Porter’s Five Forces
     4.8. Key Mergers and Acquisitions
     4.9. Regulatory Scenario

5. Global Substance Abuse Treatment Market, by Treatment Type
     5.1. Introduction and Definitions 
     5.2. Key Findings
     5.3. Global Substance Abuse Treatment Market Analysis, by Treatment Type
     5.4. Global Substance Abuse Treatment Market Forecast, by Treatment Type
           5.4.1. Alcohol Addiction Treatment
                    5.4.1.1. Acamprosate; 
                    5.4.1.2. Disulphirum; 
                    5.4.1.3. Naltrexone; 
                    5.4.1.4. Benzodiazepines Wound Care Devices
           5.4.2. Nicotine Addiction Treatment
                    5.4.2.1. Total NRT therapy ; 
                    5.4.2.2. Varenicline; 
                    5.4.2.3. Bupropion 
           5.4.3. Drug Abuse Treatment
                    5.4.3.1. Methadone; 
                    5.4.3.2. Buprenorphine; 
                    5.4.3.3. Naltexone
     5.5. Global Substance Abuse Treatment Market Attractiveness Analysis, by Treatment Type

6. Global Substance Abuse Treatment Market Analysis and Forecast, by Distribution Channel
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Global Substance Abuse Treatment Market Value Forecast, by Distribution Channel, 2016–2026 
           6.3.1. Hospital Pharmacies; 
           6.3.2. Retail Pharmacies and Drug Stores; 
           6.3.3. Others (Online Sales)
     6.4. Global Substance Abuse Treatment Market Attractiveness Analysis, by Distribution Channel 

7. Global Substance Abuse Treatment Market Analysis and Forecast, by Region
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Global Substance Abuse Treatment Market Value Forecast, by End-user, 2016–2026 
           7.3.1. North America 
           7.3.2. Europe 
           7.3.3. Asia-Pacific 
           7.3.4. Latin America
           7.3.5. Middle East & Africa 
     7.4. Global Substance Abuse Treatment Market Attractiveness Analysis, by Region 

8. North America Substance Abuse Treatment Market Analysis and Forecast, 2018-2026
     8.1. Key Findings
     8.2. North America Substance Abuse Treatment Market Overview
     8.3. North America Substance Abuse Treatment Market Value Share Analysis, by Country
     8.4. North America Substance Abuse Treatment Market Size and Forecast, by Country
           8.4.1. U.S.
           8.4.2. Canada
     8.5. North America Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
     8.6. North America Substance Abuse Treatment Market Size and Forecast, by Treatment Type
           8.6.1. Alcohol Addiction Treatment
                    8.6.1.1. Acamprosate; 
                    8.6.1.2. Disulphirum; 
                    8.6.1.3. Naltrexone; 
                    8.6.1.4. Benzodiazepines
           8.6.2. Nicotine Addiction Treatment
                    8.6.2.1. Total NRT therapy ; 
                    8.6.2.2. Varenicline; 
                    8.6.2.3. Bupropion 
           8.6.3. Drug Abuse Treatment
                    8.6.3.1. Methadone; 
                    8.6.3.2. Buprenorphine; 
                    8.6.3.3. Naltexone
     8.7. North America Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel 
     8.8. North America Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
           8.8.1. Hospital Pharmacies; 
           8.8.2. Retail Pharmacies and Drug Stores; 
           8.8.3. Others (Online Sales)
     8.9. North America Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
           8.9.1. By Treatment Type
           8.9.2. By Distribution Channel
           8.9.3. By Country 

9. Europe Substance Abuse Treatment Market Analysis and Forecast, 2018-2026
     9.1. Key Findings
     9.2. Europe Substance Abuse Treatment Market Overview
     9.3. Europe Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
     9.4. Europe Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
           9.4.1. Germany
           9.4.2. France
           9.4.3. U.K.
           9.4.4. Spain
           9.4.5. Italy
           9.4.6. Russia
           9.4.7. Rest of Europe
     9.5. Europe Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
     9.6. Europe Substance Abuse Treatment Market Size and Forecast, by Treatment Type
           9.6.1. Alcohol Addiction Treatment
                    9.6.1.1. Acamprosate; 
                    9.6.1.2. Disulphirum; 
                    9.6.1.3. Naltrexone; 
                    9.6.1.4. Benzodiazepines 
           9.6.2. Nicotine Addiction Treatment
                    9.6.2.1. Total NRT therapy ; 
                    9.6.2.2. Varenicline; 
                    9.6.2.3. Bupropion 
           9.6.3. Drug Abuse Treatment
                    9.6.3.1. Methadone; 
                    9.6.3.2. Buprenorphine; 
                    9.6.3.3. Naltexone
     9.7. Europe Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel 
     9.8. Europe Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
           9.8.1. Hospital Pharmacies; 
           9.8.2. Retail Pharmacies and Drug Stores; 
           9.8.3. Others (Online Sales)
     9.9. Europe Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
           9.9.1. By Treatment Type
           9.9.2. By Distribution Channel
           9.9.3. By Country/Sub-region 

10. Asia Pacific Substance Abuse Treatment Market Analysis and Forecast, 2018-2026
     10.1. Key Findings
     10.2. Asia Pacific Substance Abuse Treatment Market Overview
     10.3. Asia Pacific Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
     10.4. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
           10.4.1. China
           10.4.2. Japan
           10.4.3. India
           10.4.4. Australia & New Zealand
           10.4.5. Rest of Asia Pacific 
     10.5. Asia Pacific Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
     10.6. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Treatment Type
           10.6.1. Alcohol Addiction Treatment
                    10.6.1.1. Acamprosate; 
                    10.6.1.2. Disulphirum; 
                    10.6.1.3. Naltrexone; 
                    10.6.1.4. Benzodiazepines 
           10.6.2. Nicotine Addiction Treatment
                    10.6.2.1. Total NRT therapy ; 
                    10.6.2.2. Varenicline; 
                    10.6.2.3. Bupropion 
           10.6.3. Drug Abuse Treatment
                    10.6.3.1. Methadone; 
                    10.6.3.2. Buprenorphine; 
                    10.6.3.3. Naltexone
     10.7. Asia Pacific Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel 
     10.8. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
           10.8.1. Hospital Pharmacies; 
           10.8.2. Retail Pharmacies and Drug Stores; 
           10.8.3. Others (Online Sales)
     10.9. Asia Pacific Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
           10.9.1. By Treatment Type
           10.9.2. By Distribution Channel
           10.9.3. By Country/Sub-region 

11. Latin America Substance Abuse Treatment Market Analysis and Forecast, 2018-2026
     11.1. Key Findings
     11.2. Latin America Substance Abuse Treatment Market Overview
     11.3. Latin America Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
     11.4. Latin America Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
           11.4.1. Brazil
           11.4.2. Mexico
           11.4.3. Rest of Latin America 
     11.5. Latin America Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
     11.6. Latin America Substance Abuse Treatment Market Size and Forecast, by Treatment Type
           11.6.1. Alcohol Addiction Treatment
                    11.6.1.1. Acamprosate; 
                    11.6.1.2. Disulphirum; 
                    11.6.1.3. Naltrexone; 
                    11.6.1.4. Benzodiazepines 
           11.6.2. Nicotine Addiction Treatment
                    11.6.2.1. Total NRT therapy ; 
                    11.6.2.2. Varenicline; 
                    11.6.2.3. Bupropion 
           11.6.3. Drug Abuse Treatment
                    11.6.3.1. Methadone; 
                    11.6.3.2. Buprenorphine; 
                    11.6.3.3. Naltexone
     11.7. Latin America Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel 
     11.8. Latin America Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
           11.8.1. Hospital Pharmacies; 
           11.8.2. Retail Pharmacies and Drug Stores; 
           11.8.3. Others (Online Sales)
     11.9. Latin America Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
           11.9.1. By Treatment Type
           11.9.2. By Distribution Channel
           11.9.3. By Country/Sub-region 

12. Middle East & Africa Substance Abuse Treatment Market Analysis and Forecast, 2018-2026
     12.1. Key Findings
     12.2. Middle East & Africa Substance Abuse Treatment Market Overview
     12.3. Middle East & Africa Substance Abuse Treatment Market Value Share Analysis, by Country/Sub-region
     12.4. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Country/Sub-region
           12.4.1. South Africa
           12.4.2. GCC
           12.4.3. Israel
           12.4.4. Rest of Middle East & Africa 
     12.5. Middle East & Africa Substance Abuse Treatment Market Value Share Analysis, by Treatment Type
     12.6. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Treatment Type
           12.6.1. Alcohol Addiction Treatment
                    12.6.1.1. Acamprosate; 
                    12.6.1.2. Disulphirum; 
                    12.6.1.3. Naltrexone; 
                    12.6.1.4. Benzodiazepines 
           12.6.2. Nicotine Addiction Treatment
                    12.6.2.1. Total NRT therapy ; 
                    12.6.2.2. Varenicline; 
                    12.6.2.3. Bupropion 
           12.6.3. Drug Abuse Treatment
                    12.6.3.1. Methadone; 
                    12.6.3.2. Buprenorphine; 
                    12.6.3.3. Naltexone
     12.7. Middle East & Africa Substance Abuse Treatment Market Value Share Analysis, by Distribution Channel 
     12.8. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Distribution Channel
           12.8.1. Hospital Pharmacies; 
           12.8.2. Retail Pharmacies and Drug Stores; 
           12.8.3. Others (Online Sales)
     12.9. Middle East & Africa Substance Abuse Treatment Market Size and Forecast, by Market Attractiveness
           12.9.1. By Treatment Type
           12.9.2. By Distribution Channel
           12.9.3. By Country/Sub-region 

13. Competitive Landscape
     13.1. Competition Metrix
     13.2. Company Share
     13.3. Market Footprint Analysis 
     13.4. Company Profiles
           13.4.1. Alkermes 
                    13.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.1.2. Financial Overview 
                    13.4.1.3. Product Portfolio
                    13.4.1.4. SWOT Analysis
                    13.4.1.5. Strategic Overview
           13.4.2. Allergan PLC, 
                    13.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.2.2. Financial Overview 
                    13.4.2.3. Product Portfolio
                    13.4.2.4. SWOT Analysis
                    13.4.2.5. Strategic Overview
           13.4.3. Indivior PLC,
                    13.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.3.2. Financial Overview 
                    13.4.3.3. Product Portfolio
                    13.4.3.4. SWOT Analysis
                    13.4.3.5. Strategic Overview
           13.4.4. Noramco (part of SK Capital Partners), 
                    13.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.4.2. Financial Overview 
                    13.4.4.3. Product Portfolio
                    13.4.4.4. SWOT Analysis
                    13.4.4.5. Strategic Overview
           13.4.5. Teva Pharmaceutical Industries Ltd,
                    13.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.5.2. Financial Overview 
                    13.4.5.3. Product Portfolio
                    13.4.5.4. SWOT Analysis
                    13.4.5.5. Strategic Overview
           13.4.6. Pfizer, Inc, 
                    13.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.6.2. Financial Overview 
                    13.4.6.3. Product Portfolio
                    13.4.6.4. SWOT Analysis
                    13.4.6.5. Strategic Overview
           13.4.7. GlaxoSmithKline plc, 
                    13.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.7.2. Financial Overview 
                    13.4.7.3. Product Portfolio
                    13.4.7.4. SWOT Analysis
                    13.4.7.5. Strategic Overview
           13.4.8. Mallinckrodt plc, 
                    13.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.8.2. Financial Overview 
                    13.4.8.3. Product Portfolio
                    13.4.8.4. SWOT Analysis
                    13.4.8.5. Strategic Overview
           13.4.9. BioCorRx, Inc., 
                    13.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.9.2. Financial Overview 
                    13.4.9.3. Product Portfolio
                    13.4.9.4. SWOT Analysis
                    13.4.9.5. Strategic Overview
           13.4.10. Glenmark Pharmaceuticals Ltd 
                    13.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                    13.4.10.2. Financial Overview 
                    13.4.10.3. Product Portfolio
                    13.4.10.4. SWOT Analysis
                    13.4.10.5. Strategic Overview
     13.5. Competitive Business Strategies 

List of Tables 

Table 1: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 2: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment,
Table 3: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment,
Table 4: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016–2026
Table 5: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 6: Global Substance Abuse Treatment Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 7: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 8: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016–2026
Table 9: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016–2026
Table 10: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016–2026
Table 11: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel,
Table 12: North America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 13: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 14: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment,
Table 15: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016–2026
Table 16: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016–2026
Table 17: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 18: Europe Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 19: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 20: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016–2026
Table 21: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016–2026
Table 22: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment,
Table 23: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel,
Table 24: Asia Pacific Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 25: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 26: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016–2026
Table 27: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016–2026
Table 28: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016–2026
Table 29: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 30: Latin America Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region,
Table 31: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2016–2026
Table 32: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016–2026
Table 33: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Nicotine Addiction Treatment, 2016–2026
Table 34: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Drug Abuse Treatment, 2016–2026
Table 35: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 36: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026

List of Figures

Figure 1: Global Substance Abuse Treatment Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 2: Global Substance Abuse Treatment Market Value (US$ Mn), by Treatment Type, 2017
Figure 3: Global Substance Abuse Treatment Market Value (US$ Mn), by Distribution Channel, 2017
Figure 4: Global Substance Abuse Treatment Market Opportunity Map, by Treatment Type 
Figure 5: Global Substance Abuse Treatment Market Value (US$ Mn) Forecast, 2016–2026
Figure 6: Global Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2026
Figure 7: Global Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018–2026
Figure 8: Alcohol Addiction Treatment Segment, 2016–2026
Figure 9: Nicotine Addiction Treatment Segment, 2016–2026
Figure 10: Drug Abuse Treatment Segment, 2016–2026
Figure 11: Global Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 12: Global Substance Abuse Treatment Market Attractiveness, by Alcohol Addiction Treatment, 2018-2026
Figure 13: By Acamprosate Sub-segment, 2016–2026
Figure 14: By Disulphirum Sub-segment, 2016–2026
Figure 15: By Naltrexone Sub-segment, 2016–2026
Figure 16: By Benzodiazepine (BZD) Sub-segment, 2016–2026
Figure 17: Global Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 18: Global Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018–2026
Figure 19: by Total NRT Therapy Segment, 2016–2026
Figure 20: by Varenicline Segment, 2016–2026
Figure 21: by Bupropion Segment, 2016–2026
Figure 22: Global Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 23: Global Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 24: By Methadone Segment, 2016–2026
Figure 25: by Buprenorphine Segment, 2016–2026
Figure 26: by Naltexone Segment, 2016–2026
Figure 27: Global Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 28: Global Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 29: By Hospital Pharmacies Segment, 2016–2026
Figure 30: by Retail Pharmacies and Drug Stores Segment, 2016–2026
Figure 31: by Others (Online Sales) Segment, 2016–2026
Figure 32: Global Substance Abuse Treatment Market Attractiveness, by Region, 2018 and 2026
Figure 33: North America Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2016 and 2026
Figure 34: North America Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
Figure 35: North America Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
Figure 36: North America Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 37: North America Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
Figure 38: North America Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 39: North America Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018–2026
Figure 40: North America Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 41: North America Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 42: North America Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 43: North America Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 44: North America Substance Abuse Treatment Market Value Share, by Country, 2017 and 2026
Figure 45: North America Substance Abuse Treatment Market Attractiveness, by Country, 2018–2026
Figure 46: Europe Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2016 and 2026
Figure 47: Europe Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
Figure 48: Europe Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
Figure 49: Europe Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 50: Europe Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
Figure 51: Europe Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 52: Europe Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018–2026
Figure 53: Europe Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 54: Europe Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 55: Europe Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 56: Europe Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 57: Europe Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 58: Europe Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 59: Asia Pacific Substance Abuse Treatment Market, Y-o-Y Growth (%), by Substance Abuse Treatment, 2016 and 2026
Figure 60: Asia Pacific Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
Figure 61: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
Figure 62: Asia Pacific Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 63: Asia Pacific Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
Figure 64: Asia Pacific Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 65: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018–2026
Figure 66: Asia Pacific Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 67: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 68: Asia Pacific Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 69: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 70: Asia Pacific Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 71: Asia Pacific Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 72: Latin America Substance Abuse Treatment Market, Y-o-Y Growth (%), by Treatment Type, 2016 and 2026
Figure 73: Latin America Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
Figure 74: Latin America Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018-2026
Figure 75: Latin America Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 76: Latin America Substance Abuse Treatment Market Attractiveness, Alcohol Addiction Treatment, 2018-2026
Figure 77: Latin America Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 78: Latin America Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment, 2018–2026
Figure 79: Latin America Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 80: Latin America Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 81: Latin America Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 82: Latin America Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 83: Latin America Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 84: Latin America Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 85: Middle East & Africa Substance Abuse Treatment Market Value (US$ Mn) Forecast, 2016–2026
Figure 86: Middle East & Africa Substance Abuse Treatment Market Value Share, by Treatment Type, 2017 and 2025
Figure 87: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Treatment Type, 2018–2026
Figure 88: Middle East & Africa Substance Abuse Treatment Market Value Share, by Alcohol Addiction Treatment, 2017 and 2026
Figure 89: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Alcohol Addiction Treatment, 2018–2026
Figure 90: Middle East & Africa Substance Abuse Treatment Market Value Share, by Nicotine Addiction Treatment, 2017 and 2026
Figure 91: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Nicotine Addiction Treatment,
Figure 92: Middle East & Africa Substance Abuse Treatment Market Value Share, by Drug Abuse Treatment, 2017 and 2026
Figure 93: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Drug Abuse Treatment, 2018–2026
Figure 94: Middle East & Africa Substance Abuse Treatment Market Value Share, by Distribution Channel, 2017 and 2026
Figure 95: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Distribution Channel, 2018–2026
Figure 96: Middle East & Africa Substance Abuse Treatment Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 97: Middle East & Africa Substance Abuse Treatment Market Attractiveness, by Country/Sub-region, 2018–2026

.